This Powerful Root Destroys Ovarian, Prostate and Colon

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
176
This Powerful Root Destroys Ovarian, Prostate and Colon Cancer, and Is STRONGER THAN CHEMOTHERAPY

http://healthadvice365.com/index.php/2017/11/...motherapy/

Unfortunately, most cancer drugs that are currently on the market are not only seriously ineffective at reducing tumors permanently, but actually, cause tumors to become larger and kill the patient more quickly. More specifically, ‘metastasize’ tumors have been found, which means that they become larger and stronger than their original size. According to scientists at the Beth Israel Deaconess Medical Center in Boston, it has been reported that even some of the more expensive drugs are practically the death penalty for many of the patients who consume them.

Unfortunately in recent years, cases of Ovarian, colon, and prostate cancer have increased in the population, for this reason, today we bring you an alternative and very efficient anticancer, which we will present below.

Several studies have yielded a new discovery, which has brought a light to cancer patients and those who wish to prevent it and is nothing more and nothing less than Ginger, which is at our fingertips.

This study revealed that ginger root contains medicinal properties that specifically combat cancer. This was published in the Journal of Chemical and Toxicology indicates that gingerols and paradoxes, (substances contained in ginger), are anticancer components that can help prevent cancer. But the medicinal power of ginger does not get here.

The anti-cancer properties of ginger for women
Ovarian cancer is the most lethal gynecological cancer for women, and one of the most common today. tends to appear as a malignant transformation of the superficial epithelium, and develops as a result of the inflammation produced by ovulation.

Among the anticancer properties of ginger for women, we find gingerol, an anti-inflammatory that can find the cancer cells in the epithelial tissue of the ovary and thus inhibit the growth of them.

It also modulates the secretion of angiogenic factors – creating new blood vessels – into ovarian cancer cells. It is for this reason that ginger to prevent ovarian cancer is an excellent choice now
scientifically studied.

There are a number of new studies that show that ginger can eliminate cancer cells in the ovaries, prostate, and colon and that ginger may be more powerful than chemotherapy as an anti-cancer agent.

Ginger to Destroy Prostate Cancer

According to a study recently published in the British Journal of Nutrition, consuming 100 mg of ginger for every kilogram we weigh works to destroy malignant cells that cause prostate cancer.

The study showed that ginger extract decreased prostate cancer tumors by 56%, while it did not negatively affect healthy cells, so ginger works better than chemo.

Ginger against Cancer of Columbus
In a study published in a Nutrition Review in 2015, researchers showed that ginger not only prevents colon cancer but also removes the cancerous cells that are present in the colon, making ginger a preventative against cancer. chemotherapy and a therapeutic option for those suffering from colorectal cancer worldwide.

The research proved that the use of ginger against cancer did not affect the other cells in the body that need to be divided rapidly, such as cells in the stomach or bones. Ginger does not cause damage to healthy cells makes it a more effective remedy than chemo, since chemo if it causes the death of both cancer cells, but also healthy cells.

Discover your benefits and have a healthier and longer life, with this simple but powerful remedy.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles